Skip to main content
SpringerLink
Log in

Note sur l'activité du nitrothiamidazole dans l'anguillulose

  • Specialia
  • Published:
Experientia Aims and scope Submit manuscript

Summary

Report of the results of 12 patients suffering from an obstinate enteritis withStrongyloïdes stercoralis, who were treated with nitrothiamidazole (CIBA 32.644-Ba) Ambilhar® by the oral duct in 2 doses of 25–30 mg/kg/day for 4, 5 or 7 consecutive days. The clinical and parasitological recovery seems to be constant, quick, and lasting for those who escape a re-infestation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Secteur départemental des Grandes Endémies, Bouaké, Côte d'Ivoire

    G. Raffier

Authors
  1. G. Raffier
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

CIBA 32.644-Ba commercialisé sous le nom d'Ambilhar®, rapport CIBA 1965, Bâle, Suisse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raffier, G. Note sur l'activité du nitrothiamidazole dans l'anguillulose. Experientia 22, 826–827 (1966). https://doi.org/10.1007/BF01897441

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01897441

Search

Navigation